Background
==========

Predicting tumor response to radiotherapy is one of the major issues in cancer treatment. Predicting radiosensitivity is important for improving clinical outcome and for personalized medicine decisions of the treatment needed, doses, and fractionation schedules \[[@B1]\]. Understanding the mechanism of radiosensitiviy is also a major issue in identifying effective biomarkers and potential drug targets of radiosensitivity \[[@B2]\].

Assays evaluating radiosensitivity have been developed and tested over the last 25 years \[[@B3]\]. Recently, comprehensive gene expression analysis with high-throughput technology has been used to identify radiosensitivity classifiers as well as to elucidate the radiosensitivity mechanism in many cancer types including colorectal, cervical, breast, head and neck cancer \[[@B4]-[@B7]\]. As treatment response is related to the complex genetic biology of the cancer and host, biological interaction and factors that determine tumor response through the simultaneous genetic analysis of thousands of genes should be considered in predicting treatment outcome. The cancer cell line panel of the National Cancer Institute (NCI) has been widely used for drug screening based on relevant gene expression \[[@B8]\]. Although promising, these studies are confined to a single platform microarray and further validation and a larger dataset are needed. Moreover, individually identifying every gene with a statistically significant response is not sufficient as a biological explanation. For this reason, gene set analysis is necessary, along with defining the biological processes or pathways in expression analysis.

In this study, to identify a common radiosensitivity gene signature and relevant biological processes from a large amount of data from multiple platforms, we analyzed four types of transcript microarray data from radiosensitivity profiling of the NCI-60 cell line panel. Differentially expressed genes, depending on the radiosensitivity index (survival fraction at 2 Gy of radiation, SF2) were identified using a linear regression model. We hypothesized their roles in radiosensitivity using gene set analysis and pathway analysis.

Results
=======

Selection of a common radiosensitivity signature from four microarray platforms
-------------------------------------------------------------------------------

The study design is in Figure [1](#F1){ref-type="fig"}. Four published microarray experiments were reanalyzed to identify genes whose expression correlated with radiosensitivity in NCI-60 cancer cell lines. The SF2 radiosensitivity index was determined from previously published literature \[[@B9]\] and considered as a continuous variable ranging from 0 to 1. For gene selection, significant analysis of microarrays (SAM) was applied at the false discovery rate (FDR) of ≤0.10. This resulted in 31 genes commonly identified regardless of platforms and 179 selected from more than three platforms (Figure [2](#F2){ref-type="fig"}A and Additional file [1](#S1){ref-type="supplementary-material"}). Differences in gene expression between definitely radiosensitive and radioresistant cells by principal component analysis (PCA) showed that approximately the top 10% of radiosensitive (SF2 \<0.2) cell lines were distinguished from the bottom 10% of radioresistant lines (SF2 \>0.8) using the 31 signature genes (Figure [2](#F2){ref-type="fig"}B). Of these genes, 21 genes were downregulated and 10 were upregulated in radiosensitive cell lines (Table [1](#T1){ref-type="table"}). Reduced expression in a radiosensitive cells meant that decreased gene expression was observed in radiosensitive cells relative to radioresistant cells. Likewise, upregulation meant increased gene expression in radiosensitive cells relative to radioresistant cells. This was determined as the slope of the correlation coefficient between SF2 and gene expression. The scatter plots showing relationships between SF2 and gene expression of the 31 radiosensitivity signature genes in the four microarrays are in Additional files [2](#S2){ref-type="supplementary-material"}[3](#S3){ref-type="supplementary-material"}[4](#S4){ref-type="supplementary-material"}, and [5](#S5){ref-type="supplementary-material"}.

![Study scheme of analysis of data from four microarray experiments.](1471-2164-13-348-1){#F1}

![**Identification of 31 radiosensitivity signature genes in NCI-60 cell lines.A**. Venn diagram showing selection of 31 common radiosensitivity signature genes and 179 genes that were selected in more than three platforms from four microarray experiments. **B**. Principal component analysis with gene expression profile using 31 radiosensitivity signature genes. Each cell line is represented as a radiosensitive group (SF2 \<0.2; black), an intermediate group (SF2 between 0.2 and 0.8; red), and a radioresistant group (SF2 \>0.8; blue).](1471-2164-13-348-2){#F2}

###### 

List of 31 genes selected as a radiosensitivity signature from four microarray platforms

  **Symbol**   **Description**                                                                     **Location**          **Expression in radiosensitive cell**
  ------------ ----------------------------------------------------------------------------------- --------------------- ---------------------------------------
  ACTN1        actinin, alpha 1                                                                    Cytoplasm             Down (0.42)
  ANXA2        annexin A2                                                                          Plasma Membrane       Down (0.36)
  ANXA5        annexin A5                                                                          Plasma Membrane       Down (0.42)
  ARHGDIB      Rho GDP dissociation inhibitor (GDI) beta                                           Cytoplasm             Up (−0.49)
  CAPNS1       calpain, small subunit 1                                                            Cytoplasm             Down (0.48)
  CBR1         carbonyl reductase 1                                                                Cytoplasm             Down (0.41)
  CCND1        cyclin D1                                                                           Nucleus               Down (0.54)
  CD63         CD63 molecule                                                                       Plasma Membrane       Down (0.51)
  CORO1A       coronin, actin binding protein, 1A                                                  Cytoplasm             Up (−0.46)
  CXCR4        chemokine (C-X-C motif) receptor 4                                                  Plasma Membrane       Up (−0.46)
  DAG1         dystroglycan 1 (dystrophin-associated glycoprotein 1)                               Plasma Membrane       Down (0.60)
  EMP2         epithelial membrane protein 2                                                       Plasma Membrane       Down (0.41)
  HCLS1        hematopoietic cell-specific Lyn substrate 1                                         Nucleus               Up (−0.58)
  HTRA1        HtrA serine peptidase 1                                                             Extracellular Space   Down (0.52)
  ITGB5        integrin, beta 5                                                                    Plasma Membrane       Down (0.47)
  LAPTM5       lysosomal protein transmembrane 5                                                   Plasma Membrane       Up (−0.50)
  LRMP         lymphoid-restricted membrane protein                                                Cytoplasm             Up (−0.49)
  MYB          v-myb myeloblastosis viral oncogene homolog (avian)                                 Nucleus               Up (−0.59)
  PFN2         profilin 2                                                                          Cytoplasm             Down (0.61)
  PIR          pirin (iron-binding nuclear protein)                                                Nucleus               Down (0.43)
  PKM2         pyruvate kinase, muscle                                                             Cytoplasm             Down (0.44)
  PTMS         parathymosin                                                                        Nucleus               Down (0.48)
  PTPRC        protein tyrosine phosphatase, receptor type, C                                      Plasma Membrane       Up (−0.55)
  PTPRCAP      protein tyrosine phosphatase, receptor type, C-associated protein                   Plasma Membrane       Up (−0.49)
  PYGB         phosphorylase, glycogen; brain                                                      unknown               Down (0.35)
  RAB13        RAB13, member RAS oncogene family                                                   Plasma Membrane       Down (0.43)
  RALB         v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)                          
                                                                                                   Cytoplasm             Down (0.47)
  SCRN1        secernin 1                                                                          Cytoplasm             Down (0.40)
  SQSTM1       sequestosome 1                                                                      Cytoplasm             Down (0.48)
  TWF1         twinfilin, actin-binding protein, homolog 1 (Drosophila)                            Cytoplasm             Down (0.43)
  WAS          Wiskott-Aldrich syndrome (eczema-thrombocytopenia)                                  Cytoplasm             Up (−0.60)

"Down" refers to decreased expression observed in radiosensitive cells relative to radioresistant cells, determined as the slope of the correlation coefficient. "Up" refers to increased expression in radiosensitive cells.

Integrative functional gene set analysis using a global test
------------------------------------------------------------

To explain the biological processes and signaling pathways of radiosensitivity, a gene set functional study using a global test \[[@B10]\] was applied. The selected gene set was defined from the Kyoto encyclopedia of genes and genomes (KEGG) pathways. The adjusted p-value corrected for multiple comparisons using the Benjamini and Hochberg method \[[@B11]\] is in Table [2](#T2){ref-type="table"}. Several radiation-related functions were enriched including the cell cycle, DNA replication, cell junction, and cell adhesion (Table [2](#T2){ref-type="table"}A). In addition, several molecular pathways were overrepresented including the integrin, vascular endothelial growth factor (*VEGF*), mitogen-activated protein kinase (*MAPK*), *p53*, and *Wnt* signaling pathways (Table [2](#T2){ref-type="table"}B).

###### 

Gene set analysis using Kyoto encyclopedia of genes and genomes (KEGG) pathways

  **A**                                                                                                  
  ------------------------------ ---------------------------------- ---------- ------------- ---------- ----------
  Cell cycle & DNA replication                                                                          
                                 Cell cycle                         0.019      0.019         \< 0.001   \< 0.001
                                 DNA replication                    0.001      0.125         0.003      0.001
                                 Base excision repair               0.003      0.003         0.002      0.003
  Cell junction                                                                                         
                                 Adherens junction                  \< 0.001   \< 0.001      \< 0.001   0.001
                                 Tight junction                     0.004      0.003         0.002      0.006
                                 Gap junction                       0.011      0.007         0.015      0.014
                                                                                                         
  Cell adhesion molecules                                                                               
                                 Focal adhesion                     0.016      0.315         0.014      0.015
                                 Cell adhesion molecules            0.007      0.007         0.017      0.005
                                 Regulation of actin cytoskeleton   0.013      0.013         0.001      \< 0.001
  **B**                                                             **cDNA**   **HU-6800**   **U133**   **U95**
  Molecular pathway                                                                                     
                                 Integrin signaling pathway         \< 0.001   0.004         0.004      0.001
                                 VEGF signaling pathway             0.003      \< 0.001      \< 0.001   \< 0.001
                                 Phosphatidylinositol signaling     0.009      0.009         0.006      0.003
                                 Wnt signaling pathway              0.004      0.524         \< 0.001   \< 0.001
                                 Jak-STAT signaling pathway         0.034      0.034         \< 0.001   0.003
                                 MAPK signaling pathway             0.017      0.017         0.002      0.003
                                 ErbB signaling pathway             0.014      0.005         0.021      0.014
                                 p53 signaling pathway              0.035      0.034         0.016      0.006

Adjusted p-value using using Benjamini and Hochberg method as represented in four microarray platforms (significance cutoff is adjusted p-value \< 0.01).

Adhesion-related molecules as major components in a radiosensitivty signature
-----------------------------------------------------------------------------

To integrate the top-down and bottom-up approach, 31 radiosensitivity signature genes found through SAM analysis were compared with the gene sets found in the global test. Eight genes were functionally annotated in the global test, and their major function was examined according to KEGG pathways (Table [3](#T3){ref-type="table"}). The common function was related to cell junctions and adhesion, suggesting that adhesion-related molecules might have a major role in the mechanism of radiosensitivity.

###### 

Eight genes encoding adhesion molecules in the radiosensitivity signature and related function in KEGG pathways

  **Symbol**   **Entrez Gene Name**                             **Related function in KEGG pathways**
  ------------ ------------------------------------------------ --------------------------------------------------------------------------------------------
  CCND1        cyclin D1                                        Cell Cycle, Focal adhesion, Jak-STAT signaling pathway, p53 pathway, Wnt signaling pathway
  ACTN1        actinin, alpha 1                                 Focal adhesion, Tight junction, Adherens junction, Regulation of actin cytoskeleton
  WAS          Wiskott-Aldrich syndrome                         Regulation of actin cytoskeleton, Adherens junction,
  HCLS1        hematopoietic cell-specific Lyn substrate 1      Tight junction
  RAB13        RAB13, member RAS oncogene family                Tight junction
  PTPRC        protein tyrosine phosphatase, receptor type, C   Cell adhesion molecules (CAMs)
  ITGB5        integrin, beta 5                                 Focal adhesion, Regulation of actin cytoskeleton
  PFN2         profilin 2                                       Regulation of actin cytoskeleton

Genetic network interaction with adhesion-related molecules in the integrin signaling pathway
---------------------------------------------------------------------------------------------

To generate a genetic network for radiosensitivity, we performed ontology analysis using 179 genes that were selected from more than three platforms using SAM analysis. Statistical ranking with canonical pathways was performed using ingenuity pathway analysis (IPA) (Figure [3](#F3){ref-type="fig"}A). Overrepresented pathways were adhesion-related pathways including the integrin, actin-cytoskeleton, and focal adhesion kinase (FAK)-signaling pathway. In addition, the cell cycle and p53 signaling pathways important to radiosensitivity were also identified. To identify the influence of each gene on the integrin signaling pathway, which was the most overrepresented pathway, a gene plot was produced using the gene set determine from the global test (Figure [3](#F3){ref-type="fig"}B). Among the 31 signature genes, several were enriched, including *ACTN1*, *CAPNS1*, *ITGB5*, *RALB*, which were downregulated, and *WAS*, which was upregulated in radiosensitive cell lines. Genetic network interaction showed that adhesion-related molecules in Table [3](#T3){ref-type="table"} were involved in the integrin-signaling pathway, and that interaction existed with other signaling pathways such as the PI3K, Wnt, and MAPK signaling pathways, which were enriched, as shown in Table [2](#T2){ref-type="table"}B (Figure [3](#F3){ref-type="fig"}C, Additional file [6](#S6){ref-type="supplementary-material"}).

![**Integrin signaling pathway and its interaction as a radiosensitive target.A**. Statistical ranking of pathways with the commonly selected 179 genes using SAM analysis. The x-axis displays the -log of the p-value calculated by Fisher\'s exact test, right-tailed. **B**. Gene plot showing the influence of individual genes of the integrin signaling pathway produced by a global test. The influence on the y-axis is represented as the p-value, the extent of correlation between SF2 (radiosensitivity) and gene expression in a gene set. A lower p-value means that the gene is well correlated between SF2 and the gene expression value. **C**. Integrin signaling pathway interaction with identified adhesion molecules from the 31 radiosensitivity signature. (References from Ingenuity knowledge base, Additional file [6](#S6){ref-type="supplementary-material"}).](1471-2164-13-348-3){#F3}

Discussion
==========

The discovery of potential biomarkers and the elucidation of the mechanisms of radiosensitivity are important to developing radiosensitizers as well for predicting tumor response in radiation oncology \[[@B2],[@B12]\]. We reanalyzed four published microarray studies to identify a common radiosensitivity signature regardless of platform. This strengthened the reliability of our analysis. Using SAM, we examined each gene individually to show that the correlation with SF2 was significant. Next, we performed a gene set analysis using a global test based on a linear regression model with a well-defined gene set from KEGG pathways. A combination of both analyses found that adhesion-related molecules and several cancer-related molecular pathways were significantly enriched for radiosensitivity and these molecules were linked via the integrin signaling pathway. Using both a top-down and bottom-up approach increases the ability to determine genes and signaling pathways that are biologically explainable and statistically acceptable.

Several studies have reported possible radiosensitivity predictive genes \[[@B4],[@B7],[@B13],[@B14]\]. However, no gene is common among the previous reports. Therefore, we used four microarrays to find genes commonly identified as significant in radiosensitivity. We identified 31 common genes as well as 179 genes that were selected in more than three studies (Table [1](#T1){ref-type="table"} and Additional file [1](#S1){ref-type="supplementary-material"}). Of these 179 genes, 8 were previously reported \[[@B7],[@B9],[@B15],[@B16]\] (Additional file [7](#S7){ref-type="supplementary-material"}). Comparing the 179 genes with previous reports, the cell cycle genes *CCNA2* and *CDK6* in esophageal cancer \[[@B16]\], and the ras-related gene *RAC2* in rectal cancer \[[@B5]\] were common. Other genes that were reported previously could also be possible drug targets. The 31 signature genes had cellular functions including cell cycle and DNA repair, cell junction, and cell adhesion. Cyclin D1 (*CCND1*) is well known as a DNA repair gene and might sensitize human cancers to radiation by limiting DNA repair \[[@B15]\]. In breast cancer, overexpression of cyclin D induces radiation resistance by inhibiting apoptosiss \[[@B17]\]. In our analysis, *CCND1* was downregulated in radiosensitive cell lines, consistent with this explanation. Annexins including *ANXA2* and *ANXA5* are family of Ca^2+^-regulated membrane-binding proteins that interact with the cellular membrane. *ANXA5*, in particular, is related to induction of apoptosis and is used as an apoptosis marker \[[@B18]\]. *ACTN1WASHCLS1RAB13*, and *PFN2* are involved with cellular junctions and the actin cytoskeleton, and *PTPRC* is known for interacting with cell adhesion molecules. Cellular adhesion-mediated radioresistance is proposed to generate anti-apoptotic signals when integrin-mediated adhesion interacts with the extracellular matrix (ECM) \[[@B19],[@B20]\].

Integrins are adhesion molecules localized in the plasma membrane, and are heterodimeric glycoprotein receptors of α- and β-subunits. They directly bind to the ECM and contribute to proliferation, survival, and invasion in cancer \[[@B21]\]. In radiation biology, several studies report integrins as prognostic or therapeutic markers in several cancer types including breast, head and neck, prostate, lung, and colon cancer \[[@B22],[@B23]\]. In addition to integrin β1, which was included in our identified 179 genes and the most studied relative to radiosensitivity, our study identified integrin β5 (*ITGB5*) as a radiosensitive gene. αvβ5 receptors are considered to be potential therapeutic targets because of their anti-angiogenic and anti-metastatic effects, and cilengitidem, which is known as αvβ5 antagonist, has been studied in anti-cancer therapy \[[@B24]\]. Likewise, *ITGB5* could be a potential biomarker as a prognostic marker or radiosensitizer in radiotherapy. Using systems biology, we showed that major cancer-related signaling pathways were enriched related to radiosensitivity (Table [2](#T2){ref-type="table"}B) and that the integrin signaling pathway interacts with other pathways, including *MAPKWnt*, and *PI3K* signaling, as shown in Figure [3](#F3){ref-type="fig"}B. These findings suggest that integrin signaling with identified adhesion molecules could be central in radiosensitivity and one of the common radiosensitivity mechanisms, regardless of cell type. Our work could be the basis for future biological validation targeting integrin signaling pathways in radiosensitization.

Although we identified a common radiosensitivity signature regardless of cell type, radiosensitive cells (SF \<0.2) included cells of lymphoid origin and could have introduced bias in analysis. To exclude the effect of lymphoid origin, we adjusted correlation coefficients and p-values between radiosensitive cells (SF2 \<0.2) and radioresistant cells (SF2 ≥0.2) using mean-centering and a standardization method \[[@B25]\] (Additional file [8](#S8){ref-type="supplementary-material"}). We observed that correlation coefficients of the 31 radiosensitivity signature genes were similar before and after adjustment for the four microarrays. Therefore, we used the microarray data without artificial adjustment for cell type, which could change the true values of the experimental data.

There are two limitations to this study. First, we used NCI-60 cancer cell lines to identify common radiosensitivity signatures regardless of cell type. Defining common radiosensitive mechanisms not affected by cell type is helpful, but the actual cellular response in biological validation might differ among cell types. However, we adjusted for this effect using statistical methods. Adjusted correlation coefficients were similar to correlation coefficients before adjustment. Second, although we identified a gene signature using four microarray array platforms, using not only mRNA expression, but also comparing DNA sequences or protein expression would give a comprehensive analysis of the radiosensitivity mechanism.

Conclusions
===========

A common radiosensitivity gene signature was identified that involved 31 genes. Their major functions were in the cell cycle, cell junctions, and cell adhesion. Adhesion-related molecules were enriched in the integrin signaling pathway and could be targeted for radiosensitization. This is the first study to use multiple microarray platforms to study radiosensitivity, and might provide insights in elucidating novel therapeutic targets and common radiosensitivity mechanisms regardless of cell type.

Methods
=======

Radiosensitivity profiling and mRNA expression profiling
--------------------------------------------------------

Radiosensitivity profiling was defined as the survival fraction at 2 Gy radiation (SF2) \[[@B9]\]. Radiosensitivity signature genes were identified from previously published SF2 data on radiosensitivity profiling and gene expression profiling \[[@B8],[@B9],[@B26],[@B27]\] of the NCI-60 cell line panel. Briefly, the cells had been plated and radiated with 2 Gy of x-rays. After fixation, colonies of over 50 cells were calculated. SF2 was determined by the formula: (SF2 = number of colonies/total numbers of cells plated × plating efficiency). SF2 ranged from 0 to 1, with a lower SF2 representing more radiosensitivity. Gene expression profiling data using the NCI-60 cancer cell line panel was from cDNA and two-color arrays \[[@B8]\], and HU-6800 \[[@B26]\], HG-U133 \[[@B27]\], and HG-U95 Affymetrix microarrays \[[@B27]\], and obtained from Cellminer (<http://discover.nci.nih.gov/cellminer>) and <http://www.broadinstitute.org/mpr/NCI60/NCI60.html>. The gene expression data were acquired from the National Center for Biotechnology Information Gene Expression Omnibus (GPL1290, GSE5720, and GSE5949). Gene annotations were obtained from the SOURCE database (<http://smd.stanford.edu/cgi-bin/source/sourceSearch>. After gene annotation, we matched gene symbols among the four microarray platforms. For normalization, robust multiarray analysis (RMA) was used for normalizing Affymetrix gene chips and the linear models for microarray data (LIMMA) package was used with the R program for normalizing the two-color array \[[@B28]\]. Missing values were imputed using the K-nearest neighbor method. All acquired microarray data were from experiments using cells in the unirradiated status.

Identification of a common radiosensitive gene signature
--------------------------------------------------------

A radiosensitive signature gene was defined as a gene whose mRNA expression correlated with SF2. SF2 was defined as a continuous variable. Gene selection was performed using SAM \[[@B29]\]. Parameters for SAM analysis were test statistic, T-statistic, number of permutations = 1000, false discovery rate (FDR) = 0.1. Correlation between mRNA expression and SF2 was calculated using a quantitative method calculating the linear regression coefficient between gene expression and radiosensitivity from the linear regression model, and genes were identified under a false discovery rate of 10% for all four microarray platforms. We performed SAM for each microarray platform. A common radiosensitive gene signature were defined as genes commonly identified in all four microarray platforms. A Venn diagram was plotted using Venny (<http://bioinfogp.cnb.csic.es/tools/venny/index.html>). Principal components analysis was performed for data reduction, simplifying datasets to three dimensions for plotting purposes. Principal component analysis was conducted using R statistical software (<http://www.r-project.org>), using "princomp()" function and default options.

Gene set enrichment analysis using a global test
------------------------------------------------

To find a pathway of genes correlated with SF2, gene set analysis was performed using a global test \[[@B10]\] with a defined gene set from the Kyoto encyclopedia of genes and genomes (KEGG) pathways. This test was based on the generalized linear model and tested the null hypothesis in which all regression coefficients between SF2 and gene expression were zero. This was a score test based on random-effect modeling of parameters corresponding to the coefficients of the individual genes in a pathway. It was used to determine whether the global expression pattern of a gene set was significantly related to SF2. If the global test was significant, the genes in the gene set were more associated with SF2 than expected under a null hypothesis (not associated with SF2). These associations could involve both upregulation (positive) and downregulation (negative). Typically, a significant gene set is a combination of positively and negatively related genes. P-value was corrected for multiple comparisons using the Benjamini and Hochberg method \[[@B11]\]. An adjusted p-value under 0.01 was considered as significant. Analysis was done using R statistical software. We used function "gt" in the R package "globaltest".

Canonical pathway analysis, gene plot and genetic network representation
------------------------------------------------------------------------

In addition to gene set analysis, canonical pathway analysis was performed using 179 genes identified in more than three microarray platforms using SAM analysis. Canonical pathway analysis identified the pathways from the Ingenuity Pathways Analysis library of canonical pathways that were most significant to the 179 genes. In this test, the p-value was measured to decide the likelihood that the association between 179 genes and a given pathway was due to random chance. The smaller the p-value, the lower the likelihood of random association and the more significant the association. The significance of association between the 179 genes and the canonical pathways was measured in two ways: 1) the ratio of the number of molecules from the data set that mapped to the pathway divided by the total number of molecules that mapped to the canonical pathway; 2) Fisher's exact test to calculate a p-value determining the probability that the association between the genes in the data set and the canonical pathway was explained by chance alone. The Benjamini-Hochberg method of multiple testing was used for correction \[[@B11]\].

A gene plot exploits the fact that a global test statistic for a set of alternative covariates can be written as the weighted sum of the global test statistics for each single contributing covariate. Displaying these component global test results in a bar plot that gives insight into the subset of covariates that is most responsible for the significant test result. The plot showed the p-values of the component tests on a reversed log scale. The influence on the y-axis means the extent of correlation between SF2 and gene expression in a gene set. A lower p-value meant that the gene was well correlated between SF2 and the gene expression value.

In the genetic network, molecules were represented as nodes, and the biological relationship between two nodes was represented as an edge. All edges were supported by at least one reference from the literature, a textbook, or canonical information stored in the Ingenuity Pathways Knowledge Base. Data were analyzed using Ingenuity Pathways Analysis (Ingenuity Systems, <http://www.ingenuity.com>).
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Scatter plots of the 31 radiosensitivity signature genes between gene expression and radiosensitivity (SF2) in HU-6800 microarray.
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Scatter plots of the 31 radiosensitivity signature genes between gene expression and radiosensitivity (SF2) in Affy U133 microarray.
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Scatter plots of the 31 radiosensitivity signature between gene expression and radiosensitivity (SF2) in Affy U95 microarray.
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Interaction between identified radiosensitivity genes and target genes for the integrin signaling pathway from the Ingenuity knowledge base.
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Comparison with published radiosensitivity signatures. Previously reported genes in our gene lists are highlighted in yellow.

###### 

Click here for file

###### Additional file 8

Adjusted correlation coefficient and p-value of 31 radiosensitivity signature genes to remove the effect of lymphoid origin using mean-centering and standardization method in four microarrays.

###### 

Click here for file

Acknowledgements
================

This research was supported by the Public Welfare & Safety research program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2010--0020841) and by the Korean Government (MOEHRD) (KRF-2007-612-C00040), and by the department of internal medicine research program from the Yonsei University College of Medicine.
